Interferon Therapy Reduces the Risk for Hepatocellular Carcinoma: National Surveillance Program of Cirrhotic and Noncirrhotic Patients with Chronic Hepatitis C in Japan

19991,100 citationsJournal Article

Authors

Interferon therapy significantly reducesthe risk for hepatocellular carcinoma, especially among virologic or biochemical responders.

Good health and well-being

Published in: Annals of Internal Medicine

Volume 131, Issue 3, pp. 174-181

Field-Weighted Citation Impact: 22.29